ABBV vs ABT
By Alex · Tickerpine
AbbVie Inc. vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | ABT |
|---|---|---|
| Price | $253.35 | $94.12 |
| Market cap | $447.62B | $163.94B |
| P/E ratio | 123.6 | 26.4 |
| ROE | — | 12.33% |
| Profit margin | 5.79% | 13.90% |
| Revenue growth | 12.40% | 7.80% |
| Dividend yield | 2.73% | 2.68% |
| Beta | 0.31 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs ABT in plain English
- ABBV is the bigger company — about 2.7× the market cap of ABT.
- ABT is cheaper on earnings (P/E 26.4 vs 123.6).
- ABBV is growing revenue faster (12% vs 8%).
- ABBV has the higher dividend yield (2.73% vs 2.68%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.